French Pharma Stock News

Wondering if Planisware SAS at €17.96 is giving you value or just noise in the software sector? This article focuses squarely on what the current share price might be implying about the company. The stock has seen a mixed run, with a 23.2% return over the past month, a 2.5% decline over the last week, and returns of 22.4% decline year to date and 27.0% decline over the past year. Recent coverage around Planisware SAS has centered on how the business fits into the broader software space and...

Veolia Environnement (ENXTPA:VIE) has drawn fresh attention after agreeing to work with Amazon on a Mississippi data center project that plans to reuse more than 83 million gallons of water each year. See our latest analysis for Veolia Environnement. The recent Amazon partnership and speculation around potential participation in India based Re Sustainability coincide with a 19.24% year to date share price return and a 72.75% five year total shareholder return. This suggests that momentum has...

TF1 (ENXTPA:TFI) is back in focus after its Q1 2026 earnings call, where a 5% revenue decline contrasted with 22% growth in TF1+ digital advertising and 18% growth in overall digital revenue. See our latest analysis for TF1. At a share price of €6.76, TF1 has seen pressure in recent months. The 90 day share price return of 17.11% and the year to date share price return of 18.31% contrast with the 3 year total shareholder return of 19.46% and the 5 year total shareholder return of 12.79%,...

Crédit Agricole (ENXTPA:ACA) has just opened its 2026 earnings season with Q1 numbers that sit against a recent run of solid headline figures, capped by Q4 2025 revenue of €6.8b and basic EPS of €0.30 on net income of €901m. Over the last few quarters, the bank has seen revenue move between €6.1b and €6.8b while basic EPS ranged from €0.30 to €0.75, giving investors a clear view of how earnings track alongside a revenue base consistently above €6b. With net profit margins recently reported at...

Argan (ENXTPA:ARG) completed its first green bond issuance of €500 million. The bond was significantly oversubscribed, indicating strong investor demand. Proceeds are intended to refinance earlier debt within Argan's Green Financing Framework. For you as an investor, this move by Argan, a logistics real estate player, shows how the company is using labelled debt to align its funding with environmental objectives. Green bonds are increasingly common across European real estate as owners...

Event context and recent share price performance Tikehau Capital (ENXTPA:TKO) has drawn attention after a recent share price move, with the stock showing gains over the past week, month and past 3 months that outpace its 1 year total return. See our latest analysis for Tikehau Capital. Recent momentum in Tikehau Capital’s share price, with a 30 day share price return of 6.78% and 90 day return of 9.57%, contrasts with a 1 year total shareholder return decline of 1.23%. This suggests short...

It looks like Louis Hachette Group S.A. ( EPA:ALHG ) is about to go ex-dividend in the next 4 days. Typically, the...

Why BNP Paribas stock is back in focus after first quarter results BNP Paribas (ENXTPA:BNP) just reported first quarter net income of €3,217 million, up from €2,951 million a year earlier, drawing attention as French peers also posted higher profits but softer trading revenues versus Wall Street banks. See our latest analysis for BNP Paribas. The share price sits at €89.23 after a 7.12% 1 month share price return and an 8.92% year to date share price return. The 1 year total shareholder...

X-FAB Silicon Foundries (ENXTPA:XFAB) has just reported Q1 2026 results with recent quarterly revenue sitting at US$222.3 million in Q4 2025 and basic EPS of US$0.01, alongside trailing twelve month revenue of US$870.3 million and basic EPS of US$0.23 to close out 2025. Over the last year, revenue has moved from US$816.4 million in the trailing period to Q4 2024 to US$870.3 million by Q4 2025, while basic EPS over those same trailing periods shifted from US$0.47 to US$0.23. With net profit...

Q1 2026 revenue update and why it matters for Lisi (ENXTPA:FII) shareholders Lisi (ENXTPA:FII) reported first quarter 2026 group revenue of €468.0 million compared with €442.0 million a year earlier, an event that is likely shaping how investors currently view the stock. See our latest analysis for Lisi. The trading statement lands after a strong run in the shares, with a 30 day share price return of 12.68% and a year to date share price return of 16.26%. The 1 year total shareholder return...

Ayvens (ENXTPA:AYV) has kicked off its latest reporting cycle with quarterly revenue in the €6.2b range and Q4 2025 EPS of €0.26, set against a trailing twelve month EPS of €1.13 as the market weighs what that means for margins and momentum. Over recent periods, revenue has held around €6.2b to €6.3b per quarter while quarterly EPS moved from €0.17 in Q4 2024 to €0.26 in Q4 2025, with trailing twelve month net income reaching €922.1m. The story is increasingly about how efficiently that top...

Q4 trading update puts Rémy Cointreau in focus Rémy Cointreau (ENXTPA:RCO) moved into the spotlight after its Q4 2025-26 sales and trading update, which confirmed full-year revenue in line with company targets and reiterated guidance for lower Current Operating Profit. See our latest analysis for Rémy Cointreau. The Q4 trading update lands after a mixed spell for investors, with a 30 day share price return of 7.59% and a year to date share price return of 10.14%, set against a 1 year total...

Why Valeo’s latest AI push and guidance confirmation matter for shareholders Valeo (ENXTPA:FR) is back in focus after expanding its collaboration with Google Cloud on generative AI. The company also confirmed its 2026 earnings guidance and released first quarter 2026 sales of €5,120 million. See our latest analysis for Valeo. The latest AI partnership news and confirmed 2026 guidance arrive after a mixed run for shareholders. A 1-year total shareholder return of 26.10% contrasts with weaker...

If you are wondering whether Imerys at €22.24 is a bargain or a value trap, the key is to understand what the current price actually implies about the business. The stock has moved 1.4% over the last 7 days and 10.1% over the last 30 days, while year to date it shows a 7.3% decline and a 22.1% decline over the past year. These moves sit against a backdrop where longer term returns over 3 and 5 years are also negative, which keeps many investors focused on whether the current share price...

Schneider Electric's Wuhan factory has been recognized as a Talent Lighthouse for its use of AI to support workforce upskilling. The site is partnering with local vocational schools to help address the manufacturing skills gap in China. The initiative highlights a focus on AI in both operations and talent development alongside Schneider Electric's broader technology efforts. For investors tracking Schneider Electric, ticker ENXTPA:SU, this development adds a human capital angle to a company...

What recent returns say about Sodexo’s share performance Sodexo (ENXTPA:SW) has delivered a 1.3% gain over the past day and is roughly flat over the past week, while showing a 4.3% decline over the past month and a small 0.4% gain over the past 3 months. See our latest analysis for Sodexo. That short term share price softening sits against a much weaker picture for long term investors, with the 1 year total shareholder return of 16.6% and 5 year total shareholder return of 11.2% declines...

If you are wondering whether Legrand shares still offer value at around €151.80, the key is understanding how the current price compares with different valuation measures. The stock has declined by 0.5% over the last 7 days, but shows gains of 11.7% over 30 days, 18.8% year to date and 57.0% over 1 year, with 3 year and 5 year returns of 89.7% and 95.4% respectively. Recent coverage has focused on Legrand's position within the electrical and digital building infrastructure space and how...

Forvia (ENXTPA:FRVIA) is back in focus after agreeing to sell its Interiors Business Group to Apollo Funds, and reporting Q1 2026 unaudited sales of €5,135 million compared with €5,488 million a year earlier. See our latest analysis for Forvia. Recent news around the Interiors sale and softer Q1 2026 sales has come after a mixed period for investors, with a 1 year total shareholder return of 47.11% contrasting with a 5 year total shareholder return of 73.65% and a 90 day share price return...

Wondering if Arkema is offering value at today's price, or if the stock is fairly priced already? This article walks you through the key numbers that matter. Over the past month, the share price has returned 6.3%, contributing to an 18.4% return year to date, while the 1-year return stands at a 1.6% decline. Recent coverage has focused on how Arkema fits within the broader chemicals sector, with investors weighing its long term positioning and capital plans. This context helps explain why...

Recent share performance and business snapshot Nexans (ENXTPA:NEX) has attracted attention after a 3.3% move over the past day and a return of 37.6% over the past month, putting its recent share performance firmly in focus for investors. The company operates across power grid, power transmission, and other activities, with €7,810.0m in revenue and €214.0m in net income. Its business spans France, Canada, Norway, Italy, and other international markets. See our latest analysis for...

Wondering whether Pernod Ricard is starting to look attractive at today’s price, or if the market still sees more downside? The stock last closed at €62.84, with returns of a 4.5% decline over 7 days, 2.1% decline over 30 days, 13.9% decline year to date, 30.3% decline over 1 year, 67.0% decline over 3 years and 57.7% decline over 5 years. This naturally raises questions about how its current price stacks up against its fundamentals. Recent coverage has focused on how sentiment toward...

In April 2026, LVMH Moët Hennessy - Louis Vuitton’s shareholders approved a €13.00 per-share dividend for 2025, while the group also reported a 6% revenue decline linked partly to Middle East disruption and temporary store closures. At the same time, LVMH and its Stella McCartney brand face a U.S. lawsuit alleging anti-competitive pricing, pay disparities, and whistleblower retaliation, adding legal and governance questions to existing geopolitical and demand pressures on the luxury...

Sanofi faces a major U.S. trial in November 2026 over allegations that discontinued heartburn drug Zantac causes cancer. The company has moved Riliprubart into Phase III trials for chronic inflammatory demyelinating polyneuropathy. Sanofi also announced a €1.2b AI drug discovery partnership with Insilico Medicine. Sanofi, listed as ENXTPA:SAN, is trading at around €79.82. The share price is lower by 13.1% over the past year and 9.2% over three years, while showing an 11.1% gain over five...

Bolloré (ENXTPA:BOL) released its first quarter 2026 revenue update, reporting €815 million in total revenue compared with €782 million a year earlier. This provides a financial snapshot that may influence how investors view the stock. See our latest analysis for Bolloré. The first quarter revenue update lands after a steady run in the share price, with a 30 day share price return of 9.64% and a 12.48% year to date share price return. The 1 year total shareholder return of 0.25% contrasts...